InvestorsHub Logo
Followers 142
Posts 8676
Boards Moderated 0
Alias Born 10/07/2013

Re: Whalatane post# 113319

Thursday, 08/31/2017 5:53:21 PM

Thursday, August 31, 2017 5:53:21 PM

Post# of 430282
K-

Ralphey ...yes Amarin confirmed your view in the complaint

Are you sarcastic with him? If not, you are flat out wrong.

Study conducted in late 2015 indicates that physicians are more than three times more likely (28 percent to 8 percent) to recommend ...

Again ...

Meanwhile we do not know the details of the study, but the context suggest a different thing than you think (DS instead of V) ... it is DS vs V. I will do my best and try to as simple as possible:

We do not know what was the exact question, but more likely it was something like: "How do you treating patients with elevated triglycerides?" (and not "Do you treating patients with elevated triglycerides with DS or V?")

Why do I interpret the quote this way? Simple ... it is the logical ... as:
- not likely that 28% recommend DS instead of V and 8% recommend V instead of V ...
- 28% + 8% is 36% ... where is the other 64%

More likely ...
Q: "How do you treating patients with elevated triglycerides?"
A1: DS (26%)
A2: V (8%)
A3: L / gL or mothing (64%)

Is it help to understand ...?

Earlier on in the complaint they note that something like half the high and very high TG patients are on DS alternatives rather then Vascepa ...presumably because their insurance co declined coverage or demanded a high co pay

Really???? I am 100%+ sure that it is not due to insurance co declined coverage or demanded a high co pay of V. Your interpretation is way-off.
How do I know? Why I am sure? Simple ... it is the logical ... as:
- V was launched in early 2013
- the research was done "in 2012, Amarin commissioned Hall & Partners"

The DS alternative providers have FDA approval for what they make ...Dietary supplements

Really???? Could you cite please a date of approval of any DS?

-----------
I read the Complaint only once, but my first impression Amarin is full with genius I would like to give them extra bonus and additional 30M RSUs immediately. Detailed analysis of the case will come later (but not today) ... additional DD and research are required for it.

Best,
G

#NEWMIAMI

Disclosure:
I am long with this stock. I wrote this post myself, and it expresses my own opinions (IMHO). I am not receiving compensation for it.

Do Your Job

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News